What is the current valuation of the India Biomarker Technologies Market?

As of 2024, the market valuation was 2.25 USD Billion. Read More

What is the projected market size for the India Biomarker Technologies Market by 2035?

The market is projected to reach 5.26 USD Billion by 2035. Read More

What is the expected CAGR for the India Biomarker Technologies Market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 8.01%. Read More

Which application segments are driving growth in the India Biomarker Technologies Market?

Key application segments include Oncology, Cardiology, and Neurology, with Oncology valued at 0.9 USD Billion in 2024. Read More

What technologies are contributing to the India Biomarker Technologies Market?

Technologies such as Genomics and Bioinformatics are significant, with Bioinformatics valued at 1.0 USD Billion in 2024. Read More

Who are the leading players in the India Biomarker Technologies Market?

Key players include Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories. Read More

What are the primary end-use segments in the India Biomarker Technologies Market?

Pharmaceutical Companies and Diagnostic Laboratories are primary end-users, with Pharmaceutical Companies valued at 0.9 USD Billion in 2024. Read More

What types of biomarkers are being utilized in the India Biomarker Technologies Market?

Biomarkers for Disease Diagnosis and Drug Development are prominent, with Disease Diagnosis valued at 0.9 USD Billion in 2024. Read More

How does the market for Infectious Diseases compare to other segments?

The market for Infectious Diseases was valued at 0.3 USD Billion in 2024, indicating potential for growth. Read More

What is the growth outlook for the Bioinformatics segment in the India Biomarker Technologies Market?

The Bioinformatics segment is projected to grow from 1.0 USD Billion in 2024 to 1.36 USD Billion by 2035. Read More

India Biomarker Technologies Market

India Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035

Forecast Period

2025 - 2035

CAGR

8.01%

2018 Market Size

$ 1.39 Billion

2035 Market Size

$ 5.26 Billion

Healthcare ● Updated March 2026 Report ID: MRFR/HC/54489-HCR | Pages: 200 | Author: Vikita Thakur

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 India Biomarker Technologies Market, BY Application (USD Billion)
  1. 4.1.1 Oncology
  2. 4.1.2 Cardiology
  3. 4.1.3 Neurology
  4. 4.1.4 Infectious Diseases
  5. 4.1.5 Metabolic Disorders
2. 4.2 India Biomarker Technologies Market, BY Technology (USD Billion)
  1. 4.2.1 Genomics
  2. 4.2.2 Proteomics
  3. 4.2.3 Metabolomics
  4. 4.2.4 Immunoassays
  5. 4.2.5 Bioinformatics
3. 4.3 India Biomarker Technologies Market, BY End Use (USD Billion)
  1. 4.3.1 Pharmaceutical Companies
  2. 4.3.2 Research Institutions
  3. 4.3.3 Diagnostic Laboratories
  4. 4.3.4 Contract Research Organizations
4. 4.4 India Biomarker Technologies Market, BY Type (USD Billion)
  1. 4.4.1 Biomarkers for Disease Diagnosis
  2. 4.4.2 Biomarkers for Drug Development
  3. 4.4.3 Companion Diagnostics
  4. 4.4.4 Predictive Biomarkers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the India Biomarker Technologies Market
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the India Biomarker Technologies Market
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Agilent Technologies (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bio-Rad Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Merck KGaA (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Illumina (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Qiagen (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 PerkinElmer (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY APPLICATION
3. 6.3 INDIA MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 INDIA MARKET ANALYSIS BY END USE
5. 6.5 INDIA MARKET ANALYSIS BY TYPE
6. 6.6 KEY BUYING CRITERIA OF INDIA BIOMARKER TECHNOLOGIES MARKET
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF INDIA BIOMARKER TECHNOLOGIES MARKET
9. 6.9 DRIVERS IMPACT ANALYSIS: INDIA BIOMARKER TECHNOLOGIES MARKET
10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDIA BIOMARKER TECHNOLOGIES MARKET
11. 6.11 SUPPLY / VALUE CHAIN: INDIA BIOMARKER TECHNOLOGIES MARKET
12. 6.12 INDIA BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2024 (% SHARE)
13. 6.13 INDIA BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 INDIA BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 INDIA BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
16. 6.16 INDIA BIOMARKER TECHNOLOGIES MARKET, BY END USE, 2024 (% SHARE)
17. 6.17 INDIA BIOMARKER TECHNOLOGIES MARKET, BY END USE, 2024 TO 2035 (USD Billion)
18. 6.18 INDIA BIOMARKER TECHNOLOGIES MARKET, BY TYPE, 2024 (% SHARE)
19. 6.19 INDIA BIOMARKER TECHNOLOGIES MARKET, BY TYPE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY TECHNOLOGY, 2026-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2026-2035 (USD Billion)
  4. 7.2.4 BY TYPE, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Biomarker Technologies Market Segmentation

India Biomarker Technologies Market By Application (USD Billion, 2022-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Metabolic Disorders

India Biomarker Technologies Market By Technology (USD Billion, 2022-2035)

Genomics
Proteomics
Metabolomics
Immunoassays
Bioinformatics

India Biomarker Technologies Market By End Use (USD Billion, 2022-2035)

India Biomarker Technologies Market Companies
Research Institutions
Diagnostic Laboratories
Contract Research Organizations

India Biomarker Technologies Market By Type (USD Billion, 2022-2035)

Biomarkers for Disease Diagnosis
Biomarkers for Drug Development
Companion Diagnostics
Predictive Biomarkers

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”